JAZZ Related Major News
-
Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q1 EPS by 2c; Guides Above the Street
-
Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q4 EPS by 11c; Issues FY13 Outlook
-
Jazz Pharmaceuticals, Inc. (JAZZ) Misses Q3 EPS by 3c; Guides Slightly Below the Street
-
Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q2 EPS by 4c
-
Jazz Pharma (JAZZ) Raises FY12 Outlook
-
Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q1 EPS by 7c
-
Jazz Pharmaceuticals (JAZZ) Acquries EUSA Pharma for $650M
-
Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q4 EPS by 8c
-
Jazz Pharma (JAZZ) Guides FY12 EPS, Revs Above Views; to Close Azur Pharma Acquisition
-
Jazz Pharmaceuticals, Inc. (JAZZ) Reports In-Line Q3 EPS; Guides Above the Street
-
Jazz Pharmaceuticals (JAZZ), Azur Pharma Agree to Merger
-
Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q2 EPS by 5c; Guides FY11
-
Jazz Pharmaceuticals (JAZZ) Tops Q1 EPS by 2c; Boosts FY11 EPS Outlook
-
Jazz Pharmaceuticals (JAZZ) Tops Q4 Views; Guides FY11 Above Street
-
Jazz Pharma (JAZZ) Guides Q4 EPS, FY10 Product Sales at JPMorgan Healthcare Conference
-
Jazz Pharma (JAZZ) Tops Q3 EPS by 7c, Guides Above the Street
-
FDA Finds Jazz Pharma's (JAZZ) Fibromyalgia Drug JZP-6 Not Approvable At This Time
-
Jazz Pharmaceuticals (JAZZ) Receives CRL From FDA On JZP-6; Cannot Be Approved In Present Form
-
Jazz Pharma (JAZZ) Pummeled As FDA Panel Turns Away Fibromyalgia Drug
-
Jazz Pharma (JAZZ) Posts Q2 adj.-EPS of $0.28, Tops Views; Increases FY10 Outlook
-
Jazz Pharma (JAZZ) Reports In-Line Q1 EPS, Sales Fall Short
-
Jazz Pharma (JAZZ) Posts Q4 EPS of $0.17, Tops by 10c; Guides FY10 EPS Above Street
-
Jazz Pharma (JAZZ) Guides FY10 EPS Well Above the Street; Stock Jumping
-
Jazz Pharma (JAZZ) Swings to Q2 Profit; Guides FY09 Sales
-
Jazz Pharmaceuticals (JAZZ) Reports Large Q4 Loss
-
Jazz Pharmaceuticals (JAZZ) Reports Q2 Loss of $2.17
-
Jazz Pharmaceuticals (JAZZ) Announces Delay in Two Development Programs; Sees 8% Workforce Reduction
-
Jazz Pharmaceuticals (JAZZ) Falls Short of Q1 Estimates By 40c
-
Jazz Pharmaceuticals(Nasdaq: JAZZ) Reports a Q4 Loss
Back to JAZZ Stock Lookup
